Cita APA

Boman, A., Kokkonen, H., Ärlestig, L., Berglin, E., & Rantapää-Dahlqvist, S. (2017). Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis. Clin Rheumatol.

Citación estilo Chicago

Boman, Antonia, Heidi Kokkonen, Lisbeth Ärlestig, Ewa Berglin, y Solbritt Rantapää-Dahlqvist. "Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) but Not Sclerostin or Gene Polymorphisms Is Related to Joint Destruction in Early Rheumatoid Arthritis." Clin Rheumatol 2017.

Cita MLA

Boman, Antonia, et al. "Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) but Not Sclerostin or Gene Polymorphisms Is Related to Joint Destruction in Early Rheumatoid Arthritis." Clin Rheumatol 2017.